Islam M, Markatos C, Pirmettis I, Papadopoulos M, Karageorgos V, Liapakis G
Molecules. 2024; 29(15).
PMID: 39125051
PMC: 11314199.
DOI: 10.3390/molecules29153647.
Strnadova V, Pacesova A, Charvat V, Smotkova Z, Zelezna B, Kunes J
Biosci Rep. 2024; 44(4).
PMID: 38577975
PMC: 11043025.
DOI: 10.1042/BSR20231385.
Matsoukas M, Panagiotopoulos V, Karageorgos V, Chrousos G, Venihaki M, Liapakis G
Biology (Basel). 2024; 13(2).
PMID: 38392338
PMC: 10886364.
DOI: 10.3390/biology13020120.
Menke A
Curr Neuropharmacol. 2023; 22(5):904-915.
PMID: 37581323
PMC: 10845091.
DOI: 10.2174/1570159X21666230811141557.
Olayinka J, Akawa O, Ogbu E, Eduviere A, Ozolua R, Soliman M
Curr Res Pharmacol Drug Discov. 2023; 5:100161.
PMID: 37501771
PMC: 10368777.
DOI: 10.1016/j.crphar.2023.100161.
The historical progression of positron emission tomography research in neuroendocrinology.
Bini J
Front Neuroendocrinol. 2023; 70:101081.
PMID: 37423505
PMC: 10530506.
DOI: 10.1016/j.yfrne.2023.101081.
The Glutamatergic System in Treatment-Resistant Depression and Comparative Effectiveness of Ketamine and Esketamine: Role of Inflammation?.
Halaris A, Cook J
Adv Exp Med Biol. 2023; 1411:487-512.
PMID: 36949323
DOI: 10.1007/978-981-19-7376-5_21.
Changes in Corticotropin-Releasing Factor Receptor Type 1, Co-Expression with Tyrosine Hydroxylase and Oxytocin Neurons, and Anxiety-Like Behaviors across the Postpartum Period in Mice.
De Guzman R, Rosinger Z, Rybka K, Jacobskind J, Thrasher C, Caballero A
Neuroendocrinology. 2023; 113(8):795-810.
PMID: 36917957
PMC: 10389801.
DOI: 10.1159/000530156.
Editorial for Special Issue on "Regulation and Effect of Taurine on Metabolism".
Miyazaki T, Ito T, Baseggio Conrado A, Murakami S
Metabolites. 2022; 12(9).
PMID: 36144200
PMC: 9503843.
DOI: 10.3390/metabo12090795.
(3α,5α)3-Hydroxypregnan-20-one (3α,5α-THP) Regulation of the HPA Axis in the Context of Different Stressors and Sex.
Boero G, Tyler R, OBuckley T, Balan I, Besheer J, Morrow A
Biomolecules. 2022; 12(8).
PMID: 36009028
PMC: 9406198.
DOI: 10.3390/biom12081134.
Chronic stress-induced synaptic changes to corticotropin-releasing factor-signaling in the bed nucleus of the stria terminalis.
Maita I, Roepke T, Samuels B
Front Behav Neurosci. 2022; 16:903782.
PMID: 35983475
PMC: 9378865.
DOI: 10.3389/fnbeh.2022.903782.
Central Taurine Attenuates Hyperthermia and Isolation Stress Behaviors Augmented by Corticotropin-Releasing Factor with Modifying Brain Amino Acid Metabolism in Neonatal Chicks.
Elhussiny M, Tran P, Tsuru Y, Haraguchi S, Gilbert E, Cline M
Metabolites. 2022; 12(1).
PMID: 35050205
PMC: 8781603.
DOI: 10.3390/metabo12010083.
Sex Differences in Major Depressive Disorder (MDD) and Preclinical Animal Models for the Study of Depression.
Williams E, Mazei-Robison M, Robison A
Cold Spring Harb Perspect Biol. 2021; 14(3).
PMID: 34404738
PMC: 8886985.
DOI: 10.1101/cshperspect.a039198.
ComparativeStudyofCRHMicroinjections Into PVN and CeA Nuclei on Food Intake, Ghrelin, Leptin, and Glucose Levels in Acute Stressed Rats.
Radahmadi M, Sadat Izadi M, Rayatpour A, Ghasemi M
Basic Clin Neurosci. 2021; 12(1):133-148.
PMID: 33995935
PMC: 8114857.
DOI: 10.32598/bcn.12.1.2346.1.
The expression of mimecan in adrenal tissue plays a role in an organism's responses to stress.
Su B, Zhang Q, Li X, Yu H, Li P, Ma J
Aging (Albany NY). 2021; 13(9):13087-13107.
PMID: 33971622
PMC: 8148509.
DOI: 10.18632/aging.202991.
Sex differences in vulnerability to addiction.
Quigley J, Logsdon M, Turner C, Gonzalez I, Leonardo N, Becker J
Neuropharmacology. 2021; 187:108491.
PMID: 33567305
PMC: 7979496.
DOI: 10.1016/j.neuropharm.2021.108491.
Sex differences in CRF1, CRF, and CRFBP expression in C57BL/6J mouse brain across the lifespan and in response to acute stress.
Locci A, Yan Y, Rodriguez G, Dong H
J Neurochem. 2020; 158(4):943-959.
PMID: 32813270
PMC: 9811412.
DOI: 10.1111/jnc.15157.
Sex Differences in the Inflammatory Consequences of Stress: Implications for Pharmacotherapy.
Martinez-Muniz G, Wood S
J Pharmacol Exp Ther. 2020; 375(1):161-174.
PMID: 32759370
PMC: 7569308.
DOI: 10.1124/jpet.120.266205.
A new model for the HPA axis explains dysregulation of stress hormones on the timescale of weeks.
Karin O, Raz M, Tendler A, Bar A, Korem Kohanim Y, Milo T
Mol Syst Biol. 2020; 16(7):e9510.
PMID: 32672906
PMC: 7364861.
DOI: 10.15252/msb.20209510.
Pharmacological Treatment of Anxiety Disorders: The Role of the HPA Axis.
Tafet G, Nemeroff C
Front Psychiatry. 2020; 11:443.
PMID: 32499732
PMC: 7243209.
DOI: 10.3389/fpsyt.2020.00443.
